Hyperuricemia — Patent Landscape

Aggregated US Orange Book patent estate across every approved drug for hyperuricemia. 33 active patents protecting 4 drugs from 4+ originators. First major cliff: 2031. Daily refresh.

4
Approved drugs
33
Active US patents
68/100
Avg vulnerability
—
Annual revenue covered

Originators in Hyperuricemia

Companies holding active patents on drugs approved for this indication. Click through to each company's full patent dashboard.

Casper Pharma Llc 16 patents Ironwood Pharms Inc 8 patents Pfizer Inc. 5 patents Takeda 4 patents

Cliff calendar — next 15 years

Patent expiries per year across all drugs treating hyperuricemia. Each bar = one year. Y-axis scaled to peak year (10 patents).

6
28
10
29
10
31
3
32
4
39

Approved drugs ranked by patent estate

Drug Originator Active patents Avg vuln Revenue First cliff
Aloprim
ALLOPURINOL
 Casper Pharma Llc 16 63 — 2028-11-26
Zurampic
LESINURAD
 Ironwood Pharms Inc 8 63 — 2028-11-26
Col-Probenecid
probenecid
 Pfizer Inc. 5 76 — 2029-06-03
Uloric
FEBUXOSTAT
 Takeda 4 71 — 2031-09-08

Most attackable patents

Highest vulnerability scores in the indication — paragraph IV / IPR / design-around candidates.

Patent Drug Type Vuln Expiry
7795243 Col-Probenecid method of use 81 2029-06-03
10183012 Aloprim method of use 75 2028-11-26
8283369 Aloprim method of use 75 2028-11-26
10183012 Aloprim method of use 75 2028-11-26
8283369 Aloprim method of use 75 2028-11-26
10183012 Zurampic method of use 75 2028-11-26
8283369 Zurampic method of use 75 2028-11-26
8546437 Aloprim method of use 75 2029-04-29
8546437 Zurampic method of use 75 2029-04-29
8546437 Aloprim method of use 75 2029-04-29

Strongest defences

Lowest vulnerability scores — pillars of the indication's IP fortress.

Patent Drug Type Vuln Expiry
8546436 Aloprim composition of matter 10 2032-02-29
8546436 Zurampic composition of matter 10 2032-02-29
8546436 Aloprim composition of matter 10 2032-02-29
9956205 Aloprim method of use 68 2031-12-28
9956205 Zurampic method of use 68 2031-12-28
9956205 Aloprim method of use 68 2031-12-28
9107912 Uloric method of use 68 2031-09-08
9107912 Uloric method of use 68 2031-09-08
9216179 Aloprim method of use 68 2031-08-01
9216179 Aloprim method of use 68 2031-08-01

Related